Skip to content

AcrySof™ IQ Vivity™ DFT415 (REF DFT415.185)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

All models of AcrySof IQ Vivity (225)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652422024), received between Aug 13, 2024 and Aug 13, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Defective Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Defective Device1

Patient problems

  • Blurred Vision1
  • Diplopia/Double Vision1
  • Visual Disturbances1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 13, 2024Defective Device; Defective Device

    ADDITIONAL INFORMATION RECEIVED STATING THAT PATIENT HAD CORNEAL EDEMA POST OPERATION. ADDITIONAL INFORMATION RECEIVED STATING THAT THE PATIENT THE STILL HAD CORNEA EDEMA TWO WEEKS POST OPERATION. EDEMA PROBABLY DUE TO SECOND SURGERY FOR LENS REMOVAL. PATIENT WAS ON HYPERTONIC SODIUM CHLORIDE EYE DROPS.

    Patient problems: Blurred Vision; Diplopia/Double Vision; Visual Disturbances

    MAUDE report 19973688 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page